Bryn Mawr Trust CO Sutro Biopharma, Inc. Transaction History
Bryn Mawr Trust CO
- $5.48 Billion
- Q3 2024
A detailed history of Bryn Mawr Trust CO transactions in Sutro Biopharma, Inc. stock. As of the latest transaction made, Bryn Mawr Trust CO holds 645 shares of STRO stock, worth $1,244. This represents 0.0% of its overall portfolio holdings.
Number of Shares
645Holding current value
$1,244% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding STRO
# of Institutions
137Shares Held
62.4MCall Options Held
77.1KPut Options Held
31.4K-
Suvretta Capital Management, LLC New York, NY7.19MShares$13.9 Million0.98% of portfolio
-
Black Rock Inc. New York, NY6.91MShares$13.3 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.2MShares$8.1 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct3MShares$5.79 Million0.03% of portfolio
-
Bio Impact Capital LLC Cambridge, MA2.83MShares$5.47 Million1.53% of portfolio
About SUTRO BIOPHARMA, INC.
- Ticker STRO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 52,161,500
- Market Cap $101M
- Description
- Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-dr...